Compare Indoco Remedies with REDINGTON (INDIA) - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs REDINGTON - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

REDINGTON 
   Change

Redington India, incorporated in 1961, commenced the operations in 1993 distributing information technology (IT) products. Now the company along with its subsidiaries is in the business of end-to-end supply chain management of IT and non- IT products... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES REDINGTON INDOCO REMEDIES/
REDINGTON
 
P/E (TTM) x 128.4 9.0 1,421.7% View Chart
P/BV x 2.2 1.3 166.0% View Chart
Dividend Yield % 0.6 2.1 30.3%  

Financials

 INDOCO REMEDIES   REDINGTON
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
REDINGTON
Mar-18
INDOCO REMEDIES/
REDINGTON
5-Yr Chart
Click to enlarge
High Rs317210 151.1%   
Low Rs178110 162.5%   
Sales per share (Unadj.) Rs113.11,086.0 10.4%  
Earnings per share (Unadj.) Rs4.512.1 36.9%  
Cash flow per share (Unadj.) Rs11.813.5 87.3%  
Dividends per share (Unadj.) Rs1.002.40 41.7%  
Dividend yield (eoy) %0.41.5 26.9%  
Book value per share (Unadj.) Rs73.288.2 83.0%  
Shares outstanding (eoy) m92.15400.17 23.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.20.1 1,488.7%   
Avg P/E ratio x55.513.2 420.0%  
P/CF ratio (eoy) x21.011.8 177.5%  
Price / Book Value ratio x3.41.8 186.7%  
Dividend payout %22.419.8 112.9%   
Avg Mkt Cap Rs m22,83063,967 35.7%   
No. of employees `0005.51.8 307.5%   
Total wages/salary Rs m2,2096,530 33.8%   
Avg. sales/employee Rs Th1,910.1244,979.8 0.8%   
Avg. wages/employee Rs Th405.03,680.7 11.0%   
Avg. net profit/employee Rs Th75.52,730.7 2.8%   
INCOME DATA
Net Sales Rs m10,419434,594 2.4%  
Other income Rs m47391 12.0%   
Total revenues Rs m10,466434,985 2.4%   
Gross profit Rs m1,3498,165 16.5%  
Depreciation Rs m677569 118.9%   
Interest Rs m2351,680 14.0%   
Profit before tax Rs m4846,306 7.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m721,462 5.0%   
Profit after tax Rs m4124,844 8.5%  
Gross profit margin %12.91.9 689.3%  
Effective tax rate %15.023.2 64.5%   
Net profit margin %4.01.1 354.4%  
BALANCE SHEET DATA
Current assets Rs m5,373102,254 5.3%   
Current liabilities Rs m4,15768,879 6.0%   
Net working cap to sales %11.77.7 152.0%  
Current ratio x1.31.5 87.1%  
Inventory Days Days6826 259.6%  
Debtors Days Days7351 142.8%  
Net fixed assets Rs m6,2444,905 127.3%   
Share capital Rs m184800 23.0%   
"Free" reserves Rs m6,56634,505 19.0%   
Net worth Rs m6,75035,306 19.1%   
Long term debt Rs m1,23342 2,914.4%   
Total assets Rs m12,363108,648 11.4%  
Interest coverage x3.14.8 64.4%   
Debt to equity ratio x0.20 15,244.2%  
Sales to assets ratio x0.84.0 21.1%   
Return on assets %5.26.0 87.1%  
Return on equity %6.113.7 44.4%  
Return on capital %9.022.6 39.9%  
Exports to sales %00 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA7 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7621,290 291.7%   
Fx outflow Rs m1,143267 428.6%   
Net fx Rs m2,6191,023 256.0%   
CASH FLOW
From Operations Rs m1,2271,856 66.1%  
From Investments Rs m-1,360-191 714.0%  
From Financial Activity Rs m-388-1,990 19.5%  
Net Cashflow Rs m-521-380 136.9%  

Share Holding

Indian Promoters % 59.2 0.0 -  
Foreign collaborators % 0.0 21.0 -  
Indian inst/Mut Fund % 12.5 7.5 166.7%  
FIIs % 6.0 37.3 16.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 34.1 65.7%  
Shareholders   12,805 14,740 86.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   S.P. APPARELS  TALWALKARS BETTER VALUE  COMMEX TECHNOLOGY  THOMAS COOK INDIA  COX & KINGS  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

REDINGTON (INDIA) 2017-18 Annual Report Analysis (Annual Result Update)

Jan 18, 2019 | Updated on Jan 18, 2019

Here's an analysis of the annual report of REDINGTON (INDIA) for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of REDINGTON (INDIA). Also includes updates on the valuation of REDINGTON (INDIA).

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 20, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS